Weizmann Institute Wild Animal Gut Microbiomes Reveal New Species, Ties to Host Traits The gut microbiomes of nearly 200 animal species could serve as a resource for the discovery of new therapeutics and biotechnology applications. Israeli Startup Curesponse Targets European Pharma Market With Drug Prediction, Development Service Premium The firm's technology uses ex vivo organ culture to model cancer growth and predict a patient's tumor response to chemotherapy and targeted drugs. Israeli Startup Curesponse Raises $6M in Series A Financing The Rehovot, Israel-based precision medicine firm will use the funding to scale clinical trials and expansion to the UK. Tumor Microbiome Appears to Vary With Cancer Type A new microbiome analysis uncovered cancer type-specific bacterial community features, along with intracellular bacteria in tumor and associated immune cells. ALS Genomic Analysis Highlights Potential MicroRNA Contributor Aug 8, 2019 Researchers Propose Role For Microbes in Pancreatic Cancer Immune Features, Survival Mar 27, 2019 Gut Microbe Structural Variants Implicated in Health-Related Host Traits Sep 6, 2018 Gut Microbiome Studies Question Influence of Probiotics Mar 10, 2015 Research Group Taps NRGene to Assemble Emmer Wheat Genome Oct 16, 2014 Genomics in the Journals: Arrays 2014.10.16 Jul 29, 2014 Rosetta Genomics, Weizmann Institute Team on NGS Methods for Small RNAs Nov 6, 2013 Israeli Personalized Medicine Center Gets $50M Donation Sep 20, 2012 Q&A: Weizmann Institute's Eytan Domany Discusses a New Tool for microRNA Analysis Premium Mar 19, 2010 Q&A: Team Uses Dynamic Proteomics to Study How Multi-Drug Combinations Affect Proteins Premium Aug 5, 2009 Prolor Biotech Takes Option to Peptide Rx Candidates from Weizmann's Yeda R&D Premium Apr 1, 2009 Study IDs Chromosomal Instabilities Linked to Poor Colorectal Cancer Outcomes Breaking News FDA Revises SARS-CoV-2 Test Emergency Use Authorization Requirements to Account for Variants Geisinger Wins $5M NIH Grant to Develop Point-of-Care Genetic Diagnostic Tool Second Genome, Virginia Commonwealth University Partner on NASH Biomarker Discovery LGC Receives CE Mark for AccuPlex SARS-CoV-2, Flu A/B, RSV Reference Material Kit Esophageal Cancer Testing Firm Lucid Diagnostics Files For IPO Twist Bioscience, DeepCDR Collaborate on Antibody Library Design The Scan Booster for At-Risk The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk. Preprints OK to Mention Again Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications. Hundreds of Millions More to Share The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post. Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.